Norway's leading private healthcare company
Aleris provides a range of hospital and radiology services nationwide. Our services cover the majority of medical specialisations - and our goal is to offer comprehensive patient care from diagnosis to treatment on behalf of the national health service and to private patients.
In Norway, we have a staff of 1,100 people working at 14 hospitals and 13 radiology departments. Aleris Helse has an annual turnover of NOK 1.5 billion.
We are part of the Aleris Group, which is the largest private healthcare company in Scandinavia. The Group as a whole employs some 4,500 people and has an annual turnover of approx. NOK 5.5 billion.
Research and Development
Innovation and creative thinking are vital to successfully meet the challenges facing the healthcare sector, both today and in the future. As part of our focus on continuous improvement, Aleris has established an R&D fund.
The fund is intended to support research of direct relevance to patients and users. The fund is the only one of its kind, since it allows funds to be channelled back into our operations and reinforce our R&D efforts. The objective is both to cultivate a continuous-development culture among our employees and ensure that the initiatives supported by the fund provide Aleris’s patients and users a better, healthier life.
Care, professionalism, dedication and innovation constitute the ethical foundation that underpins our day-to-day work.
Aleris’s business idea is to enable people to live better, healthier lives and to provide benefits to society through innovative solutions. To succeed, we must provide a high-quality service. Our mission is to help give everyone a good and decent life.
Our values (Caring - Professional - Dedicated - Innovative) help us in our meetings with patients and in the performance of our day-to-day tasks. They help us when we are working with our colleagues or find ourselves in unexpected situations. They also help us when we think about what Aleris can do to become ever better - today and in the future.